Sangamo Therapeutics (SGMOQ) Research & Development (2009 - 2026)
Sangamo Therapeutics (SGMOQ) posted Research & Development of $26.57 million for Q1 2026, up 2.2% from $26.01 million a year earlier but down 15.5% from the prior quarter.
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) Research & Development (2009 - 2026) Analysis & Trends
For the trailing twelve months through Mar 31, 2026, Research & Development at Sangamo Therapeutics was $113.23 million, up 11.4% year-over-year; for FY2025, it was $112.67 million, up 1.0% from FY2024.
- Annual Research & Development shows a five-year compound annual growth rate of -9.0% (FY2020 to FY2025).
- In prior years, Sangamo Therapeutics' Research & Development was $111.52 million in FY2024 (-52.4%), $234.06 million in FY2023 (-6.3%), $249.9 million in FY2022 (+8.3%) and $230.82 million in FY2021 (+27.8%).
- Quarterly Research & Development has run from a low of $23.68 million in Q4 2024 to a high of $66.18 million in Q4 2022 over five years.
- On a year-over-year basis, Research & Development has increased in each of the last four quarters, with an average decline of 18.2% over the last eight quarters.
- The strongest year-over-year quarter for Research & Development in the past five years was Q2 2021, with growth of 44.7%; the weakest was Q2 2024, with a decline of 61.6%.
- According to Business Quant data, Research & Development for the three prior quarters was $31.44 million (Q4 2025), $28.14 million (Q3 2025) and $27.08 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Sangamo Therapeutics | 45.57 Mn | -70.94 Mn | - | 26.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 26.57 Mn |
| Dec 31, 2025 | 31.44 Mn |
| Sep 30, 2025 | 28.14 Mn |
| Jun 30, 2025 | 27.08 Mn |
| Mar 31, 2025 | 26.01 Mn |
| Dec 31, 2024 | 23.68 Mn |
| Sep 30, 2024 | 27.73 Mn |
| Jun 30, 2024 | 24.22 Mn |
| Mar 31, 2024 | 35.89 Mn |
| Dec 31, 2023 | 50.71 Mn |
| Sep 30, 2023 | 57.09 Mn |
| Jun 30, 2023 | 63.05 Mn |
| Mar 31, 2023 | 63.22 Mn |
| Dec 31, 2022 | 66.18 Mn |
| Sep 30, 2022 | 65.12 Mn |
| Jun 30, 2022 | 60.02 Mn |
| Mar 31, 2022 | 58.58 Mn |
| Dec 31, 2021 | 51.80 Mn |
| Sep 30, 2021 | 62.50 Mn |
| Jun 30, 2021 | 60.09 Mn |
API Access
Sangamo Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=SGMOQ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "SGMOQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=SGMOQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();